[1]
“THE UTILIZATION OF DIOSGENIN FOR MANAGING THE GENETICALLY TRANSMITTED OPTIC NERVE SHEATH MENINGIOMAS (ONSMS)”, JRA, vol. 6, no. 1, Feb. 2024, Accessed: Dec. 22, 2024. [Online]. Available: https://journlra.org/index.php/jra/article/view/1427